OPGEN INC

Profile

Company Names

OPGEN INC

Addresses

9717 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD 20850

708 QUINCE ORCHARD ROAD, SUITE 205, GAITHERSBURG, MD 20878

708 QUINCE ORCHARD ROAD, GAITHERSBURY, MD 20878

708 QUINCE ORCHARD ROAD, GAITHERSBURG, MD 20878

Phone Numbers

301-869-9683
240-813-1260
240-813-1273

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$84,991,152.00

Number of Funding Rounds:

16
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
16
2022-10-03 
$3,381,338.00 
$3,381,338.00 
$0.00 
Equity 
15
2021-02-11 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
14
2020-11-25 
$9,974,027.00 
$10,000,000.00 
$25,973.00 
Equity 
13
2018-07-30 
$285,512.00 
$285,512.00 
$0.00 
Equity 
12
2017-09-13 
$110,000.00 
$110,000.00 
$0.00 
Equity 
11
2017-06-06 
$500,000.00 
$1,500,000.00 
$1,000,000.00 
Debt 
10
2016-05-19 
$7,227,504.00 
$10,355,005.00 
$3,127,501.00 
Equity 
9
2015-07-14 
$2,584,090.00 
$2,584,090.00 
$0.00 
Equity 
8
2015-02-17 
$1,243,999.00 
$1,500,000.00 
$256,001.00 
Debt 
7
2014-07-11 
$1,079,917.00 
$1,500,000.00 
$420,083.00 
Debt 
6
2013-12-18 
$3,999,864.00 
$4,000,000.00 
$136.00 
Debt 
5
2012-03-05 
$6,100,000.00 
$17,000,000.00 
$10,900,000.00 
Equity 
4
2011-11-08 
$3,532,442.00 
$3,699,209.00 
$166,767.00 
Debt 
3
2010-09-21 
$11,935,601.00 
$15,722,858.00 
$3,787,257.00 
Equity 
2
2010-03-23 
$4,018,522.00 
$8,186,000.00 
$4,167,478.00 
Debt 
1
2009-11-30 
$4,018,336.00 
$4,052,000.00 
$33,664.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
BRIAN 
G 
ATWOOD 
DIRECTOR
OPGEN INC   |  FIVE PRIME THERAPEUTICS INC
BRIAN 
G. 
ATWOOD 
DIRECTOR
HELICOS BIOSCIENCES CORP   |  PHASERX INC   |  OPGEN INC   |  TRIUS THERAPEUTICS INC   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  VERSANT SIDE FUND II, LP   |  PHASERX, INC.   |  CLOVIS ONCOLOGY, INC.   |  VERACYTE, INC.   |  CERO THERAPEUTICS HOLDINGS, INC.
JOHANNES 
 
BACHER 
EXECUTIVE OFFICER
OPGEN INC
MARIO 
 
CROVETTO 
DIRECTOR
OPGEN INC
HARRY 
 
D-ANDREA 
DIRECTOR
QUICK HIT, INC   |  BLUE STRIPE SOFTWARE INC   |  FLAT WORLD KNOWLEDGE INC   |  OPGEN INC   |  QUMULO, INC.   |  BIDTELLECT, INC.
TIMOTHY 
C 
DEC 
EXECUTIVE OFFICER
OPGEN INC
TIMOTHY 
C. 
DEC 
EXECUTIVE OFFICER
OPGEN INC
COLIN 
W. 
DYKES 
EXECUTIVE OFFICER
OPGEN INC
R. 
DONALD 
ELSEY 
DIRECTOR
OPGEN INC
PRABHAVATHI 
 
FERNANDES 
DIRECTOR
CEMPRA HOLDINGS, LLC   |  CEMPRA, INC.   |  OCUGEN, INC.   |  OPGEN INC
TIMOTHY 
J.R. 
HARRIS 
DIRECTOR
OPGEN INC
DAVID 
 
HOEKZEMA 
EXECUTIVE OFFICER
OPGEN INC
TIMOTHY 
 
HOWE 
DIRECTOR
OPGEN INC   |  DICOM GRID INC   |  MOTIVO CONSULTING, INC.   |  IORA HEALTH, INC.   |  AVER INC.   |  RIALTIC, INC.
EVAN 
 
JONES 
EXECUTIVE OFFICER, DIRECTOR
OPGEN INC   |  VERACYTE, INC.   |  CAS MEDICAL SYSTEMS INC   |  FOUNDATION MEDICINE, INC.   |  FLUIDIGM CORP   |  HELIUS MINERALS LTD
KEVIN 
 
KRENITSKY 
EXECUTIVE OFFICER
FOUNDATION MEDICINE, INC.   |  OPGEN INC   |  STEMINA BIOMARKER DISCOVERY, INC.   |  LUMICELL, INC.
RONALD 
W. 
LENNOX 
DIRECTOR
OPGEN INC
LAURENCE 
R 
MCCARTHY 
DIRECTOR
OPGEN INC
COREY 
 
MULLOY 
DIRECTOR
WHOLE BODY INC   |  MOKA5 INC   |  PHARMACA INTEGRATIVE PHARMACY INC   |  OPGEN INC   |  ENTOURAGE MEDICAL TECHNOLOGIES INC   |  FIDELIS SENIORCARE INC   |  MOKA5, INC.   |  ZEROFOX, INC.   |  DATIPHY INC.   |  QUMULO, INC.   |  BITWISE ASSET MANAGEMENT, INC.   |  STELLAR CYBER INC.
TINA 
S 
NOVA 
DIRECTOR
OPGEN INC
WILLIAM 
E 
RHODES III 
DIRECTOR
OPGEN INC
WILLIAM 
E. 
RHODES III 
DIRECTOR
OPGEN INC
TOM 
 
ROSS 
EXECUTIVE OFFICER
BLUE DIAMOND TECHNOLOGIES LTD.   |  OPGEN INC   |  GRAND RIVER ASEPTIC MANUFACTURING, INC.
DAVID 
M 
RUBIN 
DIRECTOR
OPGEN INC
BIJAN 
 
SALEHIZADEH 
DIRECTOR
HYPERION THERAPEUTICS INC   |  OPGEN INC   |  PREDICTIVE BIOSCIENCES, INC   |  NAVIMED PARTNERS EXECUTIVE FUND, L.P.   |  NAVIMED PARTNERS, L.P.   |  AURIS SURGICAL ROBOTICS, INC.   |  AURIS HEALTH, INC.   |  VCR HOLDINGS, LLC   |  LUMERE, INC.   |  NAVIMED PARTNERS II, L.P.   |  NM-ASWC HOLDINGS, LLC   |  ALEDADE, INC.
VADIM 
 
SAPIRO 
EXECUTIVE OFFICER
OPGEN INC
OLIVER 
 
SCHACHT 
EXECUTIVE OFFICER, DIRECTOR
OPGEN INC
MISTI 
 
USHIO 
DIRECTOR
OPGEN INC   |  SENOVA SYSTEMS, INC.   |  TARA BIOSYSTEMS, INC.   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  GALLANT PET, INC.
TERRY 
 
WALKER 
EXECUTIVE OFFICER
OPGEN INC
ALBERT 
 
WEBER 
EXECUTIVE OFFICER
OPGEN INC
C. 
DOUGLAS 
WHITE 
EXECUTIVE OFFICER, DIRECTOR
OPGEN INC
C 
ERIC 
WINZER 
EXECUTIVE OFFICER
OPGEN INC   |  NUO THERAPEUTICS, INC.
C. ERIC 
 
WINZER 
EXECUTIVE OFFICER
OPGEN INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-12
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2022-10-03 
2021-02-24
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2021-02-11 
2020-12-04
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2020-11-25 
2018-08-03
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2018-07-30 
2017-09-21
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2017-09-13 
2017-06-20
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Debt 
2017-06-06 
2016-05-27
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2016-05-19 
2015-07-23
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Equity 
2015-07-14 
2015-02-23
D
Link
BIOTECHNOLOGY 
SERVICES-MEDICAL LABORATORIES [8071] 
DECLINE TO DISCLOSE 
Debt 
2015-02-17 
2014-07-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-07-11 
2014-04-04
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-12-18 
2013-12-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2013-12-18 
2012-03-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-05 
2012-02-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-08 
2011-12-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-11-08 
2011-02-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-21 
2010-10-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-21 
2010-05-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-23 
2010-03-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-23 
2010-01-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-30 
2009-12-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2009-11-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
ALLIANCE GLOBAL PARTNERS
8361
NONE
NONE
COWEN AND COMPANY
7616
NA
NONE
MAXIM GROUP LLC
120708
NONE
NONE
LEERINK PARTNERS LLC
39011